<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970862</url>
  </required_header>
  <id_info>
    <org_study_id>M2020288</org_study_id>
    <nct_id>NCT04970862</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration</brief_title>
  <official_title>Evaluation of the Effect of Revision Surgery of Lumbar Adjacent Segment Degeneration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University Third Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate postoperative imaging changes and clinical&#xD;
      symptom improvement in patients undergoing revision surgery for adjacent segment&#xD;
      degeneration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) scores of low back pain and leg pain</measure>
    <time_frame>2 years after revision surgery</time_frame>
    <description>Visual Analog Scale (VAS) scores of low back pain and leg pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Japanese Orthopedic Association (JOA) score</measure>
    <time_frame>2 years after revision surgery</time_frame>
    <description>Japanese Orthopedic Association (JOA) score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index (ODI)</measure>
    <time_frame>2 years after revision surgery</time_frame>
    <description>Oswestry Disability Index (ODI)</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Adjacent Segment Disease</condition>
  <condition>Adjacent Segment Degeneration</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>reversion surgery</intervention_name>
    <description>reversion surgery</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From January 2010 to June 2018, patients with lumbar spine disease hospitalized in&#xD;
        orthopedics were screened out to meet the criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For patients undergoing revision surgery in adjacent segments due to S-ASD, the&#xD;
             revision surgery is at least half a year from the first operation;&#xD;
&#xD;
          -  X-ray, CT and MRI examination data of the anterior and lateral extension of the lumbar&#xD;
             spine were available within 1 month before surgery and at the last follow-up;&#xD;
&#xD;
          -  Follow-up for at least 2 years after revision;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of congenital spinal deformity, spinal tumor, spinal&#xD;
             tuberculosis.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Weishi Li, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University Third Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Weishi Li, M.D.</last_name>
    <phone>(+86010)62017691-7011</phone>
    <email>puh3liweishi@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhuofu Li, M.D.</last_name>
    <email>bjmulizhuofu@163.com</email>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 2, 2021</study_first_submitted>
  <study_first_submitted_qc>July 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 11, 2021</last_update_submitted>
  <last_update_submitted_qc>July 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adjacent Segment Degeneration</keyword>
  <keyword>reversion surgery</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

